4.5 Article

Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies

Journal

NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 21, Issue 12, Pages 1058-1067

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nsmb.2922

Keywords

-

Funding

  1. NIH [1R01 AI084102, R01 AI084817]
  2. Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [UM1 AI100663]
  3. International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center, IAVI Collaboration for AIDS Vaccine Discovery
  4. Bill and Melinda Gates Foundation
  5. Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), NIH
  6. US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-39, DE-AC02-06CH11357]
  7. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036082, ZIAAI005024, R01AI084102, R01AI084817, R56AI084817, UM1AI100663] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Hydrocarbon stapling can restore bioactive a-helical structure to natural peptides, yielding research tools and prototype therapeutics to dissect and target protein interactions. Here we explore the capacity of peptide stapling to generate high-fidelity, protease-resistant mimics of antigenic structures for vaccine development. HIV-1 has been refractory to vaccine technologies thus far, although select human antibodies can broadly neutralize HIV-1 by targeting sequences of the gp41 juxtamembrane fusion apparatus. To develop candidate HIV-1 immunogens, we generated and characterized stabilized alpha-helices of the membrane-proximal external region (SAH-MPER) of gp41. SAH-MPER peptides were remarkably protease resistant and bound to the broadly neutralizing 4E10 and 10E8 antibodies with high affinity, recapitulating the structure of the MPER epitope when differentially engaged by the two anti-HIV Fabs. Thus, stapled peptides may provide a new opportunity to develop chemically stabilized antigens for vaccination.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available